Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EGFL7 Antikörper (AA 30-80)

EGFL7 Reaktivität: Human, Maus, Ratte ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN733988
  • Target Alle EGFL7 Antikörper anzeigen
    EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
    Bindungsspezifität
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 30-80
    Reaktivität
    Human, Maus, Ratte
    Wirt
    • 21
    • 8
    • 1
    • 1
    • 1
    Kaninchen
    Klonalität
    • 25
    • 7
    Polyklonal
    Konjugat
    • 21
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser EGFL7 Antikörper ist unkonjugiert
    Applikation
    • 19
    • 15
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Homologie
    Human,Mouse,Rat
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated synthetic peptide derived from mouse EGFL7
    Isotyp
    IgG
    Top Product
    Discover our top product EGFL7 Primärantikörper
  • Applikationshinweise
    WB 1:100-1000
    IHC-P 1:100-500
    IF(IHC-P) 1:50-200
    IF(ICC) 1:50-200
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
    Haltbarkeit
    12 months
  • Huang, Yuan, Wan, Liu, Chen, Zhan, Li: "VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network." in: International journal of clinical and experimental pathology, Vol. 7, Issue 3, pp. 1022-31, (2014) (PubMed).

  • Target
    EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
    Andere Bezeichnung
    Egfl7 (EGFL7 Produkte)
    Synonyme
    egfl7 antikoerper, MGC53105 antikoerper, EGFL7 antikoerper, zgc:136669 antikoerper, zgc:152804 antikoerper, zneu1 antikoerper, xegfl7 antikoerper, MGC147423 antikoerper, VE-statin antikoerper, Zneu1 antikoerper, NEU1 antikoerper, RP11-251M1.2 antikoerper, VE-STATIN antikoerper, ZNEU1 antikoerper, EGF like domain multiple 7 S homeolog antikoerper, EGF like domain multiple 7 antikoerper, EGF-like-domain, multiple 7 antikoerper, EGF-like domain 7 antikoerper, egfl7.S antikoerper, EGFL7 antikoerper, egfl7 antikoerper, Egfl7 antikoerper
    Hintergrund

    Synonyms: Zneu1, VE-statin, Epidermal growth factor-like protein 7, EGF-like protein 7, Multiple epidermal growth factor-like domains protein 7, Multiple EGF-like domains protein 7, NOTCH4-like protein, Vascular endothelial statin, Egfl7, Megf7

    Background: Regulates vascular tubulogenesis in vivo. Inhibits platelet-derived growth factor (PDGF)-BB-induced smooth muscle cell migration and promotes endothelial cell adhesion to the extracellular matrix and angiogenesis.

    Gen-ID
    353156
    UniProt
    Q9QXT5
Sie sind hier:
Kundenservice